This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Riken Corporation, Sumitomo Chemical Company, Limited. Active years: 2021.
Company Filing History:
1 out of 888 
1 out of 6,959 Years Active: 2021
Title: Taisuke Kadoshima: Innovator in Telencephalon Tissue Manufacturing
Introduction
Taisuke Kadoshima is a notable inventor based in Wako, Japan. He has made significant contributions to the field of stem cell research, particularly in the development of methods for producing telencephalon tissue. His innovative approach has the potential to advance our understanding of brain development and regenerative medicine.
Latest Patents
Kadoshima holds a patent for a method of manufacturing telencephalon or progenitor tissue thereof. The patent describes a process for producing more mature telencephalon or progenitor tissue in vitro from mammalian pluripotent stem cells. This method involves obtaining a telencephalon marker-positive aggregate by culturing pluripotent stem cells in suspension with specific signal inhibitors. The process further includes culturing the aggregate under high oxygen partial pressure conditions, which enhances the development of the desired tissue.
Career Highlights
Throughout his career, Kadoshima has worked with esteemed organizations such as Riken Corporation and Sumitomo Chemical Company, Limited. His work has been instrumental in advancing the field of stem cell research and tissue engineering. Kadoshima's innovative methods have garnered attention and recognition within the scientific community.
Collaborations
Kadoshima has collaborated with prominent researchers, including Yoshiki Sasai and Hideya Sakaguchi. These collaborations have contributed to the advancement of knowledge in the field of developmental biology and regenerative medicine.
Conclusion
Taisuke Kadoshima's contributions to the field of stem cell research and his innovative patent for telencephalon tissue manufacturing highlight his role as a leading inventor. His work continues to inspire advancements in regenerative medicine and our understanding of brain development.